This study investigates advanced pancreatic cancer. The purpose of this study is to evaluate a dual-target CAR-T cell therapy for this condition.
The study evaluates the safety and effectiveness of CAR-T cell therapy targeting two specific proteins found in pancreatic cancer cells. This approach is being assessed for its potential to manage the disease.
- Who can participate: Adults with advanced pancreatic cancer who have tried or cannot tolerate standard treatments may qualify. Participants need to have a good performance status and meet specific health criteria.
- Study details: Participants will receive two separate CAR-T cell infusions after chemotherapy. A placebo may be used for comparison.